Sabin Launches U.S. Phase 2 Trial of Marburg Vaccine

The Sabin Vaccine Institute has launched a Phase 2 clinical trial of its Marburg vaccine candidate in the United States, with...

Rwanda’s Health Insurance Contribution Set to Increase

Rwandans should prepare for an upcoming change in the amount they contribute to health insurance, according to Dr. Regis...